(MIT Technology Review) – In a bid to treat blindness, Life Biosciences will try out potent cellular reprogramming technology on volunteers. ER-100 turns out to be the code name of a treatment created by Life Biosciences, a small Boston startup … Read More
https://bioethics.com/archives/101350
